Genpact/$G
1D1W1MYTD1Y5YMAX
Capital at risk
About Genpact
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
- Ticker
- $G
- Sector
- Business services
- Primary listing
- NYSE
- Employees
- 141,000
- Headquarters
- Hamilton, Bermuda
- Website
- www.genpact.com
Genpact Metrics
BasicAdvanced
$6B
10.67
$3.36
0.58
$0.72
2.09%
Price and volume
Market cap
$6B
Beta
0.58
52-week high
$48.64
52-week low
$26.85
Average daily volume
2.4M
Dividend rate
$0.72
Financial strength
Current ratio
1.996
Quick ratio
1.765
Long term debt to equity
0.506
Total debt to equity
0.543
Dividend payout ratio (TTM)
20.88%
Interest coverage (TTM)
10.43%
Profitability
EBITDA (TTM)
876.979
Gross margin (TTM)
36.46%
Net profit margin (TTM)
11.10%
Operating margin (TTM)
14.96%
Effective tax rate (TTM)
23.64%
Revenue per employee (TTM)
$40,000
Management effectiveness
Return on assets (TTM)
9.18%
Return on equity (TTM)
22.45%
Valuation
Price to earnings (TTM)
10.671
Price to revenue (TTM)
1.169
Price to book
2.31
Price to tangible book (TTM)
7.9
Price to free cash flow (TTM)
11.189
Free cash flow yield (TTM)
8.94%
Free cash flow per share (TTM)
3.205
Dividend yield (TTM)
1.99%
Forward dividend yield
2.09%
Growth
Revenue change (TTM)
6.51%
Earnings per share change (TTM)
11.59%
3-year revenue growth (CAGR)
6.00%
10-year revenue growth (CAGR)
7.68%
3-year earnings per share growth (CAGR)
15.52%
10-year earnings per share growth (CAGR)
10.92%
3-year dividend per share growth (CAGR)
10.84%
What the Analysts think about Genpact
Analyst ratings (Buy, Hold, Sell) for Genpact stock.
Analyst projections of the future price of Genpact stock.
Bulls say / Bears say
Advanced Technology Solutions revenue rose 24.1% in Q2 and management lifted its full-year growth target to at least 25%. Total revenue still grew 7.1%, while adjusted EPS guidance was raised to at least 12% growth for 2026. (Genpact)
Commercial traction is strengthening: Genpact reported its largest quarterly bookings result, signed six large deals in Q2 and had 12 in the first half, twice the prior-year pace. Management also expects more than $1 billion of agentic total contract value in 2026, with over half from new clients. (MarketBeat, Yahoo Finance)
The mix is becoming more profitable and less tied to headcount. Q2 gross margin reached 36.5%, up about 60 basis points year on year, adjusted EPS rose 13.6%, and non-FTE revenue exceeded half of total revenue for the first time. (Genpact, MarketBeat)
The legacy business remains a drag: Core Business Services, which represented 73% of Q2 revenue, grew only 1.9%. Management expects it to be flat to slightly down in Q3, while exiting lower-priority work is expected to reduce 2026 growth by nearly two percentage points and may have a larger effect in 2027. (Yahoo Finance, MarketBeat)
The agentic story still needs to translate bookings into durable revenue. Genpact said very little of current Advanced Technology Solutions revenue is agentic-related, so slower client adoption, difficult implementation and competition could leave the company carrying the cost of its pivot before new work scales. (Yahoo Finance, Simply Wall St News)
Cash conversion weakened sharply despite higher reported profit. Operating cash flow was $72 million in Q2 versus $177 million a year earlier, and first-half operating cash flow fell to about $49 million from $218 million, largely because of working-capital movements. (last10k.com)
Data summarised monthly by Lightyear AI. Last updated on 15 Sept 2026.
Genpact Financial Performance
Revenues and expenses
Genpact Earnings Performance
Company profitability
Upcoming events
Genpact News
AllArticlesVideos
Funds containing Genpact
AllUSDGBPEUR
Fund name | Fund size | $G weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.16% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.16% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.13% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.13% |
iShares MSCI World Small Cap$WSML | $9B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.